{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:45:39Z","timestamp":1792586739034,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T00:00:00Z","timestamp":1317168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Low doses of dopamine agonists (DA) and levodopa are effective in the treatment of restless legs syndrome (RLS). A range of impulse control and compulsive behaviours (ICBs) have been reported following the use of DAs and levodopa in patients with Parkinson's disease. With this study we sought to assess the cross-sectional prevalence of impulse control behaviours (ICBs) in restless legs syndrome (RLS) and to determine factors associated with ICBs in a population cohort in Germany.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Several questionnaires based on validated and previously used instruments for assessment of ICBs were mailed out to patients being treated for RLS. Final diagnoses of ICBs were based on stringent diagnostic criteria after psychiatric interviews were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>10\/140 RLS patients of a clinical cohort (7.1%) were finally diagnosed with ICBs, 8 of 10 on dopamine agonist (DA) therapy, 2 of 10 on levodopa. 8 of the 10 affected patients showed more than one type of abnormal behaviour. Among those who responded to the questionnaires 6\/140 [4.3%] revealed binge eating, 5\/140 [3.6%] compulsive shopping, 3\/140 [2.1%] pathological gambling, 3\/140 [2.1%] punding, and 2\/140 [1.4%] hypersexuality in psychiatric assessments. Among those who did not respond to questionnaires, 32 were randomly selected and interviewed: only 1 patient showed positive criteria of ICBs with compulsive shopping and binge eating. ICBs were associated with higher DA dose (p = 0.001), younger RLS onset (p = 0.04), history of experimental drug use (p = 0.002), female gender (p = 0.04) and a family history of gambling disorders (p = 0.02), which accounted for 52% of the risk variance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>RLS patients treated with dopaminergic agents and dopamine agonists in particular, should be forewarned of potential side effects. A careful history of risk factors should be taken.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/1471-2377-11-117","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T02:15:21Z","timestamp":1317262521000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Frequency of impulse control behaviours associated with dopaminergic therapy in restless legs syndrome"],"prefix":"10.1186","volume":"11","author":[{"given":"Valerie","family":"Voon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schoerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vindhya","family":"Ekanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Reiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Sixel-D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,28]]},"reference":[{"key":"521_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","volume":"4","author":"RP Allen","year":"2003","unstructured":"Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J: Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003, 4: 101-119. 10.1016\/S1389-9457(03)00010-8.","journal-title":"Sleep Med"},{"key":"521_CR2","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S1474-4422(05)70139-3","volume":"4","author":"C Trenkwalder","year":"2005","unstructured":"Trenkwalder C, Paulus W, Walters AS: The restless legs syndrome. Lancet Neurol. 2005, 4: 465-475. 10.1016\/S1474-4422(05)70139-3.","journal-title":"Lancet Neurol"},{"key":"521_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.smrv.2006.01.004","volume":"10","author":"W Paulus","year":"2006","unstructured":"Paulus W, Schomburg ED: Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?. Sleep Med Rev. 2006, 10: 185-196. 10.1016\/j.smrv.2006.01.004.","journal-title":"Sleep Med Rev"},{"key":"521_CR4","volume-title":"Mov Disord","author":"RP Allen","year":"2007","unstructured":"Allen RP, Earley CJ: The role of iron in restless legs syndrome. Mov Disord. 2007"},{"key":"521_CR5","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1002\/mds.22254","volume":"23","author":"C Trenkwalder","year":"2008","unstructured":"Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C: Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord. 2008, 23: 2267-2302. 10.1002\/mds.22254.","journal-title":"Mov Disord"},{"key":"521_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1212\/01.wnl.0000238503.20816.13","volume":"67","author":"V Voon","year":"2006","unstructured":"Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, Lang AE, Miyasaki J: Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology. 2006, 67: 1254-1257. 10.1212\/01.wnl.0000238503.20816.13.","journal-title":"Neurology"},{"key":"521_CR7","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/mds.21072","volume":"21","author":"M Avanzi","year":"2006","unstructured":"Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfa F: Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord. 2006, 21: 2068-2072. 10.1002\/mds.21072.","journal-title":"Mov Disord"},{"key":"521_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.63.7.969","volume":"63","author":"D Weintraub","year":"2006","unstructured":"Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB: Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol. 2006, 63: 969-973. 10.1001\/archneur.63.7.969.","journal-title":"Arch Neurol"},{"key":"521_CR9","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/mds.21110","volume":"21","author":"KA Grosset","year":"2006","unstructured":"Grosset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, Grosset DG: Problematic gambling on dopamine agonists: Not such a rarity. Mov Disord. 2006, 21: 2206-2208. 10.1002\/mds.21110.","journal-title":"Mov Disord"},{"key":"521_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE: Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010, 67: 589-595. 10.1001\/archneurol.2010.65.","journal-title":"Arch Neurol"},{"key":"521_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/mds.20757","volume":"21","author":"MJ Nirenberg","year":"2006","unstructured":"Nirenberg MJ, Waters C: Compulsive eating and weight gain related to dopamine agonist use. Mov Disord. 2006, 21: 524-529. 10.1002\/mds.20757.","journal-title":"Mov Disord"},{"key":"521_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/mds.21296","volume":"22","author":"JM Miyasaki","year":"2007","unstructured":"Miyasaki JM, Al Hassan K, Lang AE, Voon V: Punding prevalence in Parkinson's disease. Mov Disord. 2007, 22: 1179-1181. 10.1002\/mds.21296.","journal-title":"Mov Disord"},{"key":"521_CR13","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1002\/mds.21702","volume":"22","author":"AJ Lawrence","year":"2007","unstructured":"Lawrence AJ, Blackwell AD, Barker RA, Spagnolo F, Clark L, Aitken MR, Sahakian BJ: Predictors of punding in Parkinson's disease: results from a questionnaire survey. Mov Disord. 2007, 22: 2339-2345. 10.1002\/mds.21702.","journal-title":"Mov Disord"},{"key":"521_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/mds.20045","volume":"19","author":"AH Evans","year":"2004","unstructured":"Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, Lees AJ: Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord. 2004, 19: 397-405. 10.1002\/mds.20045.","journal-title":"Mov Disord"},{"key":"521_CR15","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1212\/01.wnl.0000184487.72289.f0","volume":"65","author":"AH Evans","year":"2005","unstructured":"Evans AH, Lawrence AD, Potts J, Appel S, Lees AJ: Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease. Neurology. 2005, 65: 1570-1574. 10.1212\/01.wnl.0000184487.72289.f0.","journal-title":"Neurology"},{"key":"521_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/jnnp.68.4.423","volume":"68","author":"G Giovannoni","year":"2000","unstructured":"Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJ: Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry. 2000, 68: 423-428. 10.1136\/jnnp.68.4.423.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"521_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/archneur.64.2.212","volume":"64","author":"V Voon","year":"2007","unstructured":"Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M: Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol. 2007, 64: 212-216. 10.1001\/archneur.64.2.212.","journal-title":"Arch Neurol"},{"key":"521_CR18","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1212\/01.wnl.0000238401.76928.45","volume":"67","author":"G Pontone","year":"2006","unstructured":"Pontone G, Williams JR, Bassett SS, Marsh L: Clinical features associated with impulse control disorders in Parkinson disease. Neurology. 2006, 67: 1258-1261. 10.1212\/01.wnl.0000238401.76928.45.","journal-title":"Neurology"},{"key":"521_CR19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1176\/ajp.144.9.1184","volume":"144","author":"HR Lesieur","year":"1987","unstructured":"Lesieur HR, Blume SB: The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry. 1987, 144: 1184-1188.","journal-title":"Am J Psychiatry"},{"key":"521_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1001\/archneur.64.8.1089","volume":"64","author":"V Voon","year":"2007","unstructured":"Voon V, Fox SH: Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol. 2007, 64: 1089-1096. 10.1001\/archneur.64.8.1089.","journal-title":"Arch Neurol"},{"key":"521_CR21","volume-title":"Diagnostic and statistical manual of mental disorders: DSM-IV","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association, American Psychiatric Association. Task Force on DSM-IV: Diagnostic and statistical manual of mental disorders: DSM-IV. 1994, Washington, DC: American Psychiatric Association, 4","edition":"4"},{"key":"521_CR22","first-page":"242","volume":"55","author":"SL McElroy","year":"1994","unstructured":"McElroy SL, Keck PE, Pope HG, Smith JM, Strakowski SM: Compulsive buying: a report of 20 cases. J Clin Psychiatry. 1994, 55: 242-248.","journal-title":"J Clin Psychiatry"},{"key":"521_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jama.287.4.455","volume":"287","author":"DE Hobson","year":"2002","unstructured":"Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J: Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. Jama. 2002, 287: 455-463. 10.1001\/jama.287.4.455.","journal-title":"Jama"},{"key":"521_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.parkreldis.2007.05.006","volume":"14","author":"WG Ondo","year":"2008","unstructured":"Ondo WG, Lai D: Predictors of impulsivity and reward seeking behavior with dopamine agonists. Parkinsonism Relat Disord. 2008, 14: 28-32. 10.1016\/j.parkreldis.2007.05.006.","journal-title":"Parkinsonism Relat Disord"},{"key":"521_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/wnf.0b013e31804c780e","volume":"30","author":"ED Driver-Dunckley","year":"2007","unstructured":"Driver-Dunckley ED, Noble BN, Hentz JG, Evidente VG, Caviness JN, Parish J, Krahn L, Adler CH: Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol. 2007, 30: 249-255. 10.1097\/wnf.0b013e31804c780e.","journal-title":"Clin Neuropharmacol"},{"key":"521_CR26","first-page":"81","volume":"33","author":"JR Cornelius","year":"2010","unstructured":"Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH: Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep. 2010, 33: 81-87.","journal-title":"Sleep"},{"key":"521_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2009.11.010","volume":"290","author":"E Pourcher","year":"2010","unstructured":"Pourcher E, Remillard S, Cohen H: Compulsive habits in restless legs syndrome patients under dopaminergic treatment. J Neurol Sci. 2010, 290: 52-56. 10.1016\/j.jns.2009.11.010.","journal-title":"J Neurol Sci"},{"key":"521_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/mds.21872","volume":"23","author":"IU Isaias","year":"2008","unstructured":"Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A: The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord. 2008, 23: 411-415. 10.1002\/mds.21872.","journal-title":"Mov Disord"},{"key":"521_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00415-009-5301-5","volume":"257","author":"C Siri","year":"2010","unstructured":"Siri C, Cilia R, De Gaspari D, Canesi M, Meucci N, Zecchinelli AL, Pezzoli G, Antonini A: Cognitive status of patients with Parkinson's disease and pathological gambling. J Neurol. 2010, 257: 247-252.","journal-title":"J Neurol"},{"key":"521_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/mds.20288","volume":"20","author":"FR Pezzella","year":"2005","unstructured":"Pezzella FR, Colosimo C, Vanacore N, Di Rezze S, Chianese M, Fabbrini G, Meco G: Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease. Mov Disord. 2005, 20: 77-81. 10.1002\/mds.20288.","journal-title":"Mov Disord"},{"key":"521_CR31","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.biopsych.2006.03.040","volume":"61","author":"JI Hudson","year":"2007","unstructured":"Hudson JI, Hiripi E, Pope HG, Kessler RC: The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007, 61: 348-358. 10.1016\/j.biopsych.2006.03.040.","journal-title":"Biol Psychiatry"},{"key":"521_CR32","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1176\/ajp.2006.163.10.1806","volume":"163","author":"LM Koran","year":"2006","unstructured":"Koran LM, Faber RJ, Aboujaoude E, Large MD, Serpe RT: Estimated prevalence of compulsive buying behavior in the United States. Am J Psychiatry. 2006, 163: 1806-1812. 10.1176\/appi.ajp.163.10.1806.","journal-title":"Am J Psychiatry"},{"key":"521_CR33","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jpsychires.2009.04.003","volume":"43","author":"A Preti","year":"2009","unstructured":"Preti A, Girolamo G, Vilagut G, Alonso J, Graaf R, Bruffaerts R, Demyttenaere K, Pinto-Meza A, Haro JM, Morosini P: The epidemiology of eating disorders in six European countries: results of the ESEMeD-WMH project. J Psychiatr Res. 2009, 43: 1125-1132. 10.1016\/j.jpsychires.2009.04.003.","journal-title":"J Psychiatr Res"},{"key":"521_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.286.2.141","volume":"286","author":"MN Potenza","year":"2001","unstructured":"Potenza MN, Kosten TR, Rounsaville BJ: Pathological gambling. JAMA. 2001, 286: 141-144. 10.1001\/jama.286.2.141.","journal-title":"JAMA"},{"key":"521_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1024\/2007.05.06","volume":"53","author":"G Buhringer","year":"2007","unstructured":"Buhringer G, Kraus L, Sonntag D, Pfeiffer-Gerschel T, Steiner S: Pathological gambling in Germany: Gambling and population based risks. SUCHT. 2007, 53: 296-308.","journal-title":"SUCHT"},{"key":"521_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/00002018-200932060-00004","volume":"32","author":"A Antonini","year":"2009","unstructured":"Antonini A, Cilia R: Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. Drug Saf. 2009, 32: 475-488. 10.2165\/00002018-200932060-00004.","journal-title":"Drug Saf"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-11-117\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-11-117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T12:59:50Z","timestamp":1630501190000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-11-117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,28]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-11-117","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,28]]},"assertion":[{"value":"3 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"117"}}